Consumer telehealth · Employer obesity management
Calibrate
Calibrate provides physician-guided obesity and metabolic health programs sold primarily to employers and health plans to manage outcomes and GLP-1 spend. It is not a hospital EHR.
Strong fit
- Employers and health plans that need an obesity program aimed at GLP-1 cost management with coaching and outcomes tracking
- Benefits leaders comparing enterprise metabolic health vendors rather than consumer compounded-semaglutide brands
- Organizations that want medication plus curriculum and coaching, not medication alone
Weak fit
- Individuals hunting the lowest cash-pay compounded tirzepatide refill
- Health systems that will only refer into their own endocrinology department
- Buyers who need an on-prem population-health data platform rather than a virtual care program
Bottom line
Calibrate earns a Recommend for employer and plan buyers focused on obesity management and GLP-1 spend control. After shifting from a consumer-heavy model to enterprise clients (now the large majority of the book), CEO Rob Rebak's team sells physician-guided metabolic care with coaching and outcome reporting. Third-party estimates cluster around roughly $50–70M revenue with a few hundred employees, under the hard cap. Implementation for employers is benefits and PBM coordination more than IT install. Consumer ease of signup is less central than it was in the DTC era. Score sits just under Form Health on one-to-one specialty clinic feel and above cash-pay compounders when the purchasing problem is employer GLP-1 unit cost and adherence.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Calibrate is a New York metabolic health company founded by Isabelle Kenyon and now led by CEO Rob Rebak. The program combines physician oversight, coaching curriculum, and medication when appropriate, with a 2025–2026 pivot that made employers and plans the primary customer.
It is an obesity management program for benefits buyers, not a hospital EMR and not a pure compounding marketplace. Compare Form Health when the narrative is ABOM specialty clinic care, Found when the buy is a consumer weight-care brand, and Henry Meds when members only want low-cost compounded incretins.
Score reflects solid employer-fit product marks with the usual opacity of benefits contracting.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Employer and plan-contracted obesity management program with coaching; medication billed through pharmacy benefits separately. |
| What usually drives cost | Covered lives, clinical intensity, coaching cadence, reporting package, and PBM coordination scope. |
| What to ask in diligence | PEPM or program fee plus expected GLP-1 plan liability under your formulary rules. |
| Published pricing | Enterprise pricing is quote-based via calibratehealth.com / joincalibrate.com; not a public consumer price list. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Calibrate to function | |
| Employer or plan sponsor contracted | No sponsor means no enterprise launch. |
| PBM and formulary rules aligned | GLP-1 cost goals fail otherwise. |
| Eligibility and exclusion criteria published | Wrong members drive complaints. |
| Coaching and clinical escalation path defined | Medication-only workflows miss the product. |
| HR communications owner named | Enrollment stays thin without outreach. |
| What will maximize your value | |
| Enroll target cohort in first 60 days | Slow enrollment wastes contract year. |
| Report GLP-1 spend and adherence monthly | Finance needs the metric. |
| Close the loop on prior-auth delays | Medication gaps drive dropout. |
| Deal-breakers | |
| Individual compounded refill only | |
| No benefits or plan partner | |
| Requires on-prem pop-health warehouse | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contracting and PBM setup | 4-10 weeks |
| 2 | Member enrollment | 4-8 weeks |
| 3 | Outcomes reporting | ongoing |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.